DoctorDirectory to co-market VoSpire ER with Dava Pharmaceuticals

DoctorDirectory’s IncreaseRx utilizes web-based educational and promotional tactics to reach tens of thousands of interested prescribers with targeted sales and marketing messages. Essentially, IncreaseRx performs as a virtual contract sales organization providing e-sampling and online educational tools.

VoSpire ER is indicated for the relief of bronchospasm in adults and children six years of age and older with reversible obstructive airway disease.

Jay Grobowsky, CEO of DoctorDirectory, said: “Our team is looking forward to promoting VoSpire ER with Dava. Albuterol sulfate remains a standard of long-lasting oral therapy for patients.”